93 related articles for article (PubMed ID: 9704727)
1. Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: a prospective assessment.
Saliba F; Hagipantelli R; Misset JL; Bastian G; Vassal G; Bonnay M; Herait P; Cote C; Mahjoubi M; Mignard D; Cvitkovic E
J Clin Oncol; 1998 Aug; 16(8):2745-51. PubMed ID: 9704727
[TBL] [Abstract][Full Text] [Related]
2. A blind, randomized comparison of racecadotril and loperamide for stopping acute diarrhea in adults.
Wang HH; Shieh MJ; Liao KF
World J Gastroenterol; 2005 Mar; 11(10):1540-3. PubMed ID: 15770734
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of kampo medicines and baicalin against intestinal toxicity of a new anticancer camptothecin derivative, irinotecan hydrochloride (CPT-11), in rats.
Takasuna K; Kasai Y; Kitano Y; Mori K; Kobayashi R; Hagiwara T; Kakihata K; Hirohashi M; Nomura M; Nagai E
Jpn J Cancer Res; 1995 Oct; 86(10):978-84. PubMed ID: 7493918
[TBL] [Abstract][Full Text] [Related]
4. Racecadotril in the treatment of acute diarrhea in children: a systematic, comprehensive review and meta-analysis of randomized controlled trials.
Eberlin M; Chen M; Mueck T; Däbritz J
BMC Pediatr; 2018 Apr; 18(1):124. PubMed ID: 29614995
[TBL] [Abstract][Full Text] [Related]
5. Medicinal grade opium tincture for severe diarrhea: effect revisited in observational study.
Dahlgren D; Hellström PM
Curr Opin Gastroenterol; 2024 May; 40(3):196-202. PubMed ID: 37903075
[TBL] [Abstract][Full Text] [Related]
6. [Delayed diarrhea induced by irinotecan: from the perspective of gut microbiota].
Zhang ZY; Duan LP
Zhonghua Nei Ke Za Zhi; 2024 May; 63(5):507-511. PubMed ID: 38715491
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation studies of novel carboxylesterase 2 inhibitors for the treatment of irinotecan-induced delayed diarrhea.
Yang Z; Cao Z; Wang W; Chen Y; Huang W; Jiao S; Chen S; Chen L; Liu Y; Mao J; Zhang L; Li Z
Bioorg Chem; 2023 Sep; 138():106625. PubMed ID: 37300962
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel carboxylesterase 2 inhibitors for the treatment of delayed diarrhea and ulcerative colitis.
Cao Z; Liu Y; Chen S; Wang W; Yang Z; Chen Y; Jiao S; Huang W; Chen L; Sun L; Li Z; Zhang L
Biochem Pharmacol; 2023 Sep; 215():115742. PubMed ID: 37567318
[TBL] [Abstract][Full Text] [Related]
9. CDK4/6 inhibition confers protection of normal gut epithelia against gemcitabine and the active metabolite of irinotecan.
Blume J; Claus L; Isermann T; Dickmanns A; Conradi LC; Schulz-Heddergott R; Dobbelstein M
Cell Cycle; 2023 Jul; 22(13):1563-1582. PubMed ID: 37266562
[TBL] [Abstract][Full Text] [Related]
10. Mitigating acute chemotherapy-associated adverse events in patients with cancer.
Kuderer NM; Desai A; Lustberg MB; Lyman GH
Nat Rev Clin Oncol; 2022 Nov; 19(11):681-697. PubMed ID: 36221000
[TBL] [Abstract][Full Text] [Related]
11. A Review of Potential Role of Capsule Endoscopy in the Work-Up for Chemotherapy-Induced Diarrhea.
Ando T; Sakumura M; Mihara H; Fujinami H; Yasuda I
Healthcare (Basel); 2022 Jan; 10(2):. PubMed ID: 35206833
[TBL] [Abstract][Full Text] [Related]
12. A Pilot Study of Silymarin as Supplementation to Reduce Toxicities in Metastatic Colorectal Cancer Patients Treated With First-Line FOLFIRI Plus Bevacizumab.
Chang TK; Yin TC; Su WC; Tsai HL; Huang CW; Chen YC; Li CC; Chen PJ; Ma CJ; Chuang KH; Cheng TL; Wang JY
Oncol Res; 2021 Sep; 28(7):801-809. PubMed ID: 34030768
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Expression Profile of Irinotecan-Induced Diarrhea in Patients with Colorectal Cancer.
Okunaka M; Kano D; Matsui R; Kawasaki T; Uesawa Y
Pharmaceuticals (Basel); 2021 Apr; 14(4):. PubMed ID: 33921605
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-induced bowel ischemia: diagnostic imaging overview.
Reginelli A; Sangiovanni A; Vacca G; Belfiore MP; Pignatiello M; Viscardi G; Clemente A; Urraro F; Cappabianca S
Abdom Radiol (NY); 2022 May; 47(5):1556-1564. PubMed ID: 33811514
[TBL] [Abstract][Full Text] [Related]
15. The Exciting New Field of HER2-Low Breast Cancer Treatment.
Eiger D; Agostinetto E; Saúde-Conde R; de Azambuja E
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33804398
[TBL] [Abstract][Full Text] [Related]
16. Tdp1 protects from topoisomerase 1-mediated chromosomal breaks in adult zebrafish but is dispensable during larval development.
Zaksauskaite R; Thomas RC; van Eeden F; El-Khamisy SF
Sci Adv; 2021 Jan; 7(5):. PubMed ID: 33514542
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).
Schmidt-Hieber M; Bierwirth J; Buchheidt D; Cornely OA; Hentrich M; Maschmeyer G; Schalk E; Vehreschild JJ; Vehreschild MJGT;
Ann Hematol; 2018 Jan; 97(1):31-49. PubMed ID: 29177551
[TBL] [Abstract][Full Text] [Related]
18. Irinotecan-Induced Gastrointestinal Dysfunction Is Associated with Enteric Neuropathy, but Increased Numbers of Cholinergic Myenteric Neurons.
McQuade RM; Stojanovska V; Donald EL; Rahman AA; Campelj DG; Abalo R; Rybalka E; Bornstein JC; Nurgali K
Front Physiol; 2017; 8():391. PubMed ID: 28642718
[TBL] [Abstract][Full Text] [Related]
19. Quality of life with cediranib in relapsed ovarian cancer: The ICON6 phase 3 randomized clinical trial.
Stark DP; Cook A; Brown JM; Brundage MD; Embleton AC; Kaplan RS; Raja FA; Swart AMW; Velikova G; Qian W; Ledermann JA
Cancer; 2017 Jul; 123(14):2752-2761. PubMed ID: 28339098
[TBL] [Abstract][Full Text] [Related]
20. A Comprehensive Comparison of the Efficacy and Tolerability of Racecadotril with Other Treatments of Acute Diarrhea in Adults.
Fischbach W; Andresen V; Eberlin M; Mueck T; Layer P
Front Med (Lausanne); 2016; 3():44. PubMed ID: 27790616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
